Calpain Inhibitors as Potential Therapeutic Modulators in Neurodegenerative Diseases

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Neurodegenerative disorders present a significant challenge due to complex neuronal cell death mechanisms.
• Calpains, a class of cysteine proteases, are implicated as key mediators and markers in the pathophysiology of brain disorders.
• Calpain activation is a critical factor driving apoptotic machinery in degenerating neurons.

Purpose of the Study:

• To review the fundamental pathobiology of calpains in neurodegeneration.
• To explore the role of selective calpain inhibitors as a therapeutic strategy.
• To identify calpain inhibition as a potential therapeutic target for neurodegenerative diseases.

Main Methods:

• A systematic literature review was performed.
• Databases searched include PubMed, Medline, Bentham, Scopus, and EMBASE (Elsevier).

Main Results:

• Calpain activation is a central neurodegenerative factor.
• Inhibition of calpain activation has emerged as a viable therapeutic approach.
• Selective calpain inhibitors are being investigated for various neurodegenerative conditions.

Conclusions:

• Developing effective approaches to prevent calpain-mediated apoptosis is crucial.
• Targeting calpain activation represents a promising therapeutic avenue for neurodegenerative diseases.
• Further research into selective calpain inhibitors is warranted for clinical application.